Our findings clearly indicate that the supplementation of GO ameliorates blood and plasma glucose levels, HbA1c level, HOMA-IR value, adiposity and hepatic steatosis in type 2 diabetic db/db mice, at least in part, through the preservation of β-cell insulin expression and hepatic insulin sensitivity. Here, INS is linked to fatty liver disease.